Clinical study for women and men with HIV infection
In a clinical study of the Charité Research Organization, a new drug against the HIV virus will be investigated. It is a new substance in the class of nucleoside reverse transcriptase inhibitors (NRTIs).
For this study we are looking for:
- Women and men with HIV infection,
- between the ages of 18 and 60,
- that have not received any HIV therapy yet.
Patients from other federal states can also come for the study on the Berlin Charité. The program will cover the travel costs.
During the study, you will be required to stay in hospital (2 nights), as well, as several outpatient appointments in our study center.
For participation in the study, you will receive a compensation of 2200, – €.